InvestorsHub Logo
Followers 2
Posts 108
Boards Moderated 0
Alias Born 08/13/2019

Re: None

Friday, 04/10/2020 11:46:56 AM

Friday, April 10, 2020 11:46:56 AM

Post# of 233377
In this interview on Cheddar, Dr. Nader Pourhassan advised that Leronlimab will be free to the 1st 10,000 patients and that CytoDyn would be paid via a government grant-Assuming Leronlimab gets approved to treat COVID-19. Perhaps CYDY can price Leronlimab 50% of treating HIV per injection works out to $451 per treatment. Anybody care to guesstimate what we may be looking at here? When I hear ‘grant,’ my excitement wains. I realize we are in a pandemic; however, should Leronlimab be approved, CYDY is in no financial position to give this product away for free or to lose money.

At the very least, I would expect enough funds to ensure CytoDyn completes HIV FDA submission along with cancer and other indications. If Leronlimab emerges as the most used treatment, this would obviously potentially save many lives and allow for a quicker return to normal, which would be a huge boost to the world’s economy.

From what I have researched on the web, there is no consensus knock it out of the ballpark treatment being used on a wide scale. If there was, why are we approaching 100,000 deaths? If Chloroquine phosphate works, then no one should be dying. Yesterday’s news touted an MD combining this drug with zinc. I assume the CYDY team will keep us up-to-date, we usual, and we will know a lot more in the coming weeks.

https://cheddar.com/media/cytodyn-ceo-on-fast-tracking-companys-hiv-drug-to-help-coronavirus-patients-in-critical-condition
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News